Stay updated with breaking news from Eric Venker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Edge Wealth Management LLC reduced its stake in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 23.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 134,528 shares of the company’s stock after selling 41,004 shares during the period. Edge Wealth Management LLC’s holdings […]
Roivant Sciences (NASDAQ:ROIV – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $16.00 to $15.00 in a report issued on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. Several other research analysts also recently weighed in on ROIV. Truist Financial reissued a buy rating and […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12 […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 153,027 shares of the company’s stock in a transaction dated Thursday, October 5th. The shares were sold at an average price of $10.11, for a total value of $1,547,102.97. Following the completion of the transaction, the chief operating officer now owns 595,397 shares […]
On October 5, 2023, Eric Venker, the COO of Roivant Sciences Ltd (NASDAQ:ROIV), sold 1,200,000 shares of the company.